A novel patient-derived xenograft model for claudin-low triple negative breast cancer

BACKGROUND: Triple negative breast cancer (TNBC) subtypes are clinically aggressive and are treated with targeted therapeutics commonly used in other BC subtypes. The claudin-low (CL) molecular subtype of TNBC has high rates of metastases, chemoresistance and recurrence. There exists an urgent need...

詳細記述

保存先:
書誌詳細
出版年:Breast Cancer Res Treat
主要な著者: Matossian, Margarite D., Burks, Hope E., Bowles, Annie C., Elliott, Steven, Hoang, Van T., Sabol, Rachel A., Pashos, Nicholas, O’Donnell, Benjamen, Miller, Kristin S., Wahba, Bahia M., Bunnell, Bruce A., Moroz, Krzysztof, Zea, Arnold H., Jones, Steven D., Ochoa, Augusto C., Al-Khami, Amir, Hossain, Fokhrul, Riker, Adam I., Rhodes, Lyndsay V., Martin, Elizabeth C., Miele, Lucio, Burow, Matthew E., Collins-Burow, Bridgette M.
フォーマット: Artigo
言語:Inglês
出版事項: 2018
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5948145/
https://ncbi.nlm.nih.gov/pubmed/29392581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-018-4685-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料